STOCK TITAN

Paragon 28 To Report Second Quarter 2022 Financial Results on August 3, 2022

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Paragon 28, Inc. (NYSE: FNA) will report its second quarter 2022 financial results after market close on August 3, 2022. A conference call will follow at 4:30 p.m. ET, accessible via phone (domestic: 844-200-6205, international: 929-526-1599) with conference ID: 990038, or through a webcast on the company's website. Paragon 28 focuses on innovative orthopedic solutions for foot and ankle conditions, aiming to enhance patient outcomes and reduce complications.

Positive
  • None.
Negative
  • None.

ENGLEWOOD, Colo.--(BUSINESS WIRE)-- Paragon 28, Inc. (NYSE: FNA) (“PARAGON”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, announced it will report financial results for the second quarter 2022 after market close on Wednesday, August 3, 2022. The company’s management will webcast a corresponding conference call beginning at 4:30 p.m. Eastern Time.

Investors interested in listening to the conference call may do so by dialing (844-200-6205) for domestic callers or (929-526-1599) for international callers, using conference ID: 990038. Live audio of the webcast will be available on the “Investors” section of the company’s website at: ir.paragon28.com. The webcast will be archived and available for replay for at least 90 days after the event.

About Paragon 28, Inc.

Based in Englewood, Colo., Paragon 28, is a leading medical device company exclusively focused on the foot and ankle orthopedic market and is dedicated to improving patient lives. From the onset, Paragon 28® has provided innovative orthopedic solutions, procedural approaches and instrumentation that cover a wide range of foot and ankle ailments including fracture fixation, hallux valgus (bunions), hammertoe, ankle, progressive collapsing foot deformity (PCFD) or flatfoot, charcot foot and orthobiologics. The company designs products with both the patient and surgeon in mind, with the goal of improving outcomes, reducing ailment recurrence and complication rates, and making the procedures simpler, consistent, and reproducible.

Investor Contact:

Gilmartin Group

Matt Bacso, CFA

Matt.bacso@gilmartinir.com

Source: Paragon 28, Inc.

FAQ

When will Paragon 28 report its financial results for Q2 2022?

Paragon 28 will report its financial results for Q2 2022 after market close on August 3, 2022.

How can I listen to the Paragon 28 conference call?

You can listen to the conference call by dialing 844-200-6205 for domestic callers or 929-526-1599 for international callers, using conference ID: 990038. The call will also be available via webcast on their website.

What time is the Paragon 28 conference call scheduled?

The Paragon 28 conference call is scheduled to begin at 4:30 p.m. Eastern Time.

Paragon 28, Inc.

NYSE:FNA

FNA Rankings

FNA Latest News

FNA Stock Data

831.64M
49.79M
40.56%
61.27%
8.11%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
ENGLEWOOD